Compare JM Mid Cap Fund vs Invesco India Mid Cap Fund
JM Mid Cap Fund
EquityMid Cap
Invesco India Mid Cap Fund
EquityMid Cap
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.47
1.87
NAV
₹18.78
₹176.84
Fund Started
31 Oct 2022
15 Feb 2007
Fund Size
₹1303.39 Cr
₹15748.83 Cr
Exit Load
Exit load of 1% if redeemed within 180 days.
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year
-4.38%
-5.11%
3 Year
13.94%
18.90%
5 Year
-
14.95%
Equity
98.36%
98.74%
Cash
1.64%
1.26%
Top 10 Holdings
Name | Assets |
|---|---|
One 97 Communications Ltd. | 3.60% |
Avalon Technologies Ltd. | 3.08% |
Mankind Pharma Ltd. | 2.89% |
Godfrey Phillips India Ltd. | 2.86% |
IDFC First Bank Ltd. | 2.84% |
Bank of Maharashtra | 2.81% |
Marico Ltd. | 2.74% |
Glenmark Pharmaceuticals Ltd. | 2.66% |
Sona BLW Precision Forgings Ltd. | 2.39% |
Multi Commodity Exchange Of India Ltd. | 2.28% |
Name | Assets |
|---|---|
Prestige Estates Projects Ltd. | 7.33% |
Max Healthcare Institute Ltd. | 7.21% |
Meesho Ltd. | 5.42% |
The Federal Bank Ltd. | 5.37% |
Manipal Health Enterprises Ltd. | 4.44% |
Eternal Ltd. | 4.14% |
Global Health Ltd. | 3.97% |
L&T Finance Ltd. | 3.91% |
AU Small Finance Bank Ltd. | 3.81% |
Indusind Bank Ltd. | 3.51% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. There is no assurance that the investment objective of the Scheme will be realized.
The scheme seeks to generate capital appreciation by investing predominantly in Mid cap entities.
Launch Date
31 Oct 2022
15 Feb 2007
